Report cover image

EU5 Cardiac Disease Market Outlook to 2033 - Cardiac Marker Tests

Publisher GlobalData
Published Jul 09, 2025
Length 84 Pages
SKU # GBDT20238044

Description

EU5 Cardiac Disease Market Outlook to 2033 - Cardiac Marker Tests

Summary


GlobalData’s “EU5 Cardiac Disease Market Outlook to 2033” is a comprehensive databook report, covering key market data on the EU5 Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests

The EU5 Cardiac Disease Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Cardiac Disease Market.
  • Global corporate-level profiles of key companies operating within the EU5 Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

EU5 Cardiac Disease is segmented as follows -
  • Cardiac Marker Tests
Reasons to Buy

The EU5 Cardiac Disease Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

84 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Disease Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Disease Market, EU5
3.1 Cardiac Disease Market, EU5, Revenue ($m), 2018-2033
3.2 Cardiac Disease Market, EU5, Revenue ($m), 2018-2033
3.3 Cardiac Disease Market, EU5, Volume (Units), 2018-2033
3.4 Cardiac Disease Market, EU5, Volume (Units), 2018-2033
3.5 Cardiac Disease Market, EU5, Company Share by Revenue ($m), 2024
4 Cardiac Disease Market, France
4.1 Cardiac Disease Market, France, Revenue ($m), 2018-2033
4.1.1 Cardiac Marker Tests Market, France, Revenue ($m), by Segment, 2018-2033
4.2 Cardiac Disease Market, France, Volume (Units), 2018-2033
4.2.1 Cardiac Marker Tests Market, France, Volume (Units), by Segment, 2018-2033
4.3 Cardiac Disease Market, France, Average Price ($), 2018-2033
4.4 Cardiac Disease Market, France, Company Share by Revenue ($m), 2024
5 Cardiac Disease Market, Italy
5.1 Cardiac Disease Market, Italy, Revenue ($m), 2018-2033
5.1.1 Cardiac Marker Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
5.2 Cardiac Disease Market, Italy, Volume (Units), 2018-2033
5.2.1 Cardiac Marker Tests Market, Italy, Volume (Units), by Segment, 2018-2033
5.3 Cardiac Disease Market, Italy, Average Price ($), 2018-2033
5.4 Cardiac Disease Market, Italy, Company Share by Revenue ($m),2024
6 Cardiac Disease Market, Spain
6.1 Cardiac Disease Market, Spain, Revenue ($m), 2018-2033
6.1.1 Cardiac Marker Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
6.2 Cardiac Disease Market, Spain, Volume (Units), 2018-2033
6.2.1 Cardiac Marker Tests Market, Spain, Volume (Units), by Segment, 2018-2033
6.3 Cardiac Disease Market, Spain, Average Price ($), 2018-2033
6.4 Cardiac Disease Market, Spain, Company Share by Revenue ($m), 2024
7 Cardiac Disease Market, Germany
7.1 Cardiac Disease Market, Germany, Revenue ($m), 2018-2033
7.1.1 Cardiac Marker Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
7.2 Cardiac Disease Market, Germany, Volume (Units), 2018-2033
7.2.1 Cardiac Marker Tests Market, Germany, Volume (Units), by Segment, 2018-2033
7.3 Cardiac Disease Market, Germany, Average Price ($), 2018-2033
7.4 Cardiac Disease Market, Germany, Company Share by Revenue ($m), 2024
8 Cardiac Disease Market, United Kingdom
8.1 Cardiac Disease Market, United Kingdom, Revenue ($m), 2018-2033
8.1.1 Cardiac Marker Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
8.2 Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
8.2.1 Cardiac Marker Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
8.3 Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
8.4 Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
9 Overview of Key Companies in EU5 Cardiac Disease Market
9.1 Abbott Laboratories
9.1.1 Company Overview
9.2 F. Hoffmann-La Roche Ltd
9.2.1 Company Overview
9.3 Siemens Healthineers AG
9.3.1 Company Overview
9.4 Beckman Coulter Inc
9.4.1 Company Overview
9.5 Quidel Corp
9.5.1 Company Overview
9.6 bioMerieux SA
9.6.1 Company Overview
10 Cardiac Disease Market Pipeline Products
11 Recent Developments
11.1 Corporate Communications
11.1.1 Sep 30, 2024: EDX Medical Group: Annual General Meeting Results
11.2 Financial Announcements
11.2.1 Sep 04, 2024: EDX Medical Group Releases Annual Report and Financial Statements for the Period Ending March 31, 2024
11.3 Other Significant Developments
11.3.1 Oct 09, 2024: Heart Health for All: How We Can Improve Access to Cardiac Care around the Globe
11.3.2 Sep 20, 2024: Funding Supports Neuranics’ Groundbreaking AI Technology for Remote Heart Health Monitoring
11.4 Product News
11.4.1 Apr 28, 2025: Simple Blood Test Could Better Predict Heart Disease Risk
11.4.2 Oct 30, 2024: Market Report Highlights Opportunity for Consumer Wearables to Enhance Accuracy and Build Trust with Providers
11.4.3 Jul 22, 2024: Accelerating Genomics through Automated RNA Sequencing
11.5 Strategy And Business Planning
11.5.1 Feb 13, 2025: Hemolens Diagnostics Expands International Cooperation in the Field of in Silico Medical Technology
11.5.2 Sep 20, 2024: Funding Supports Neuranics’ Groundbreaking AI Technology for Remote Heart Health Monitoring
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Market Modeling and Forecasting
12.1.5 Company Share Analysis
12.1.6 Benchmarking
12.2 GlobalData Consulting
12.3 Contact Us
12.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Disease Market, EU5, Revenue ($m), USD Constant, 2018-2033
Table 3: Cardiac Disease Market, EU5, Volume (Units), 2018-2033
Table 4: Cardiac Disease Market, EU5, Volume (Units), 2018-2033
Table 5: Cardiac Disease Market, EU5, Company Share by Revenue ($m), 2024
Table 6: Cardiac Disease Market, France, Revenue ($m), USD Constant, 2018-2033
Table 7: Cardiac Marker Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 8: Cardiac Disease Market, France, Volume (Units), 2018-2033
Table 9: Cardiac Marker Tests Market, France, Volume (Units), 2018-2033
Table 10: Cardiac Disease Market, France, Average Price ($), 2018-2033
Table 11: Cardiac Disease Market, France, Company Share by Revenue ($m), 2024
Table 12: Cardiac Disease Market, Italy, Revenue ($m), USD Constant, 2018-2033
Table 13: Cardiac Marker Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
Table 14: Cardiac Disease Market, Italy, Volume (Units), 2018-2033
Table 15: Cardiac Marker Tests Market, Italy, Volume (Units), 2018-2033
Table 16: Cardiac Disease Market, Italy, Average Price ($), 2018-2033
Table 17: Cardiac Disease Market, Italy, Company Share by Revenue ($m), 2024
Table 18: Cardiac Disease Market, Spain, Revenue ($m), USD Constant, 2018-2033
Table 19: Cardiac Marker Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
Table 20: Cardiac Disease Market, Spain, Volume (Units), 2018-2033
Table 21: Cardiac Marker Tests Market, Spain, Volume (Units), 2018-2033
Table 22: Cardiac Disease Market, Spain, Average Price ($), 2018-2033
Table 23: Cardiac Disease Market, Spain, Company Share by Revenue ($m), 2024
Table 24: Cardiac Disease Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 25: Cardiac Marker Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 26: Cardiac Disease Market, Germany, Volume (Units), 2018-2033
Table 27: Cardiac Marker Tests Market, Germany, Volume (Units), 2018-2033
Table 28: Cardiac Disease Market, Germany, Average Price ($), 2018-2033
Table 29: Cardiac Disease Market, Germany, Company Share by Revenue ($m), 2024
Table 30: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 31: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 32: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
Table 33: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
Table 34: Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
Table 35: Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
Table 41: Cardiac Disease Market Pipeline Products
Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Disease Market, EU5, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cardiac Disease Market, EU5, Volume (Units), 2018-2033
Figure 4: Cardiac Disease Market, EU5, Volume (Units), 2018-2033
Figure 5: Cardiac Disease Market, EU5, Company Share (%), 2024
Figure 6: Cardiac Disease Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 7: Cardiac Marker Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 8: Cardiac Disease Market, France, Volume (Units), 2018-2033
Figure 9: Cardiac Marker Tests Market, France, Volume (Units), 2018-2033
Figure 10: Cardiac Disease Market, France, Company Share (%), 2024
Figure 11: Cardiac Disease Market, Italy, Revenue ($m), USD Constant, 2018-2033
Figure 12: Cardiac Marker Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
Figure 13: Cardiac Disease Market, Italy, Volume (Units), 2018-2033
Figure 14: Cardiac Marker Tests Market, Italy, Volume (Units), 2018-2033
Figure 15: Cardiac Disease Market, Italy, Company Share (%), 2024
Figure 16: Cardiac Disease Market, Spain, Revenue ($m), USD Constant, 2018-2033
Figure 17: Cardiac Marker Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
Figure 18: Cardiac Disease Market, Spain, Volume (Units), 2018-2033
Figure 19: Cardiac Marker Tests Market, Spain, Volume (Units), 2018-2033
Figure 20: Cardiac Disease Market, Spain, Company Share (%), 2024
Figure 21: Cardiac Disease Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 22: Cardiac Marker Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 23: Cardiac Disease Market, Germany, Volume (Units), 2018-2033
Figure 24: Cardiac Marker Tests Market, Germany, Volume (Units), 2018-2033
Figure 25: Cardiac Disease Market, Germany, Company Share (%), 2024
Figure 26: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 27: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 28: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
Figure 29: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
Figure 30: Cardiac Disease Market, United Kingdom, Company Share (%), 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us